5C57.1

ICD-11 MMS 2026-01

Disorders of peroxisomal alpha-, beta- or omega-oxidation

Index terms

  • Disorders of peroxisomal alpha-, beta- or omega-oxidation
  • Refsum disease
  • HMSN 4 - [Hereditary motor and sensory neuropathy type 4]
Show allHide
  • Hereditary motor and sensory neuropathy type 4
  • Heredoataxia hemeralopica polyneuritiformis
  • Phytanic acid oxidase deficiency
  • Phytanic acid storage disease
  • Refsum-Thiebaut disease
  • Infantile Refsum disease
  • X-linked adrenoleukodystrophy
  • Schilder-Addison complex
  • X-linked cerebral adrenoleukodystrophy
  • X-linked childhood adrenoleukodystrophy
  • Adrenomyeloneuropathy
  • X-linked adult-onset adrenomyeloneuropathy
  • Peroxisomal D-bifunctional enzyme deficiency
  • Bifunctional enzyme deficiency
  • Peroxisomal acyl-CoA oxidase deficiency
  • Pseudo-neonatal adrenoleukodystrophy
  • Pseudoadrenoleukodystrophy
  • Sterol carrier protein deficiency

Exclusions from above levels

  • http://id.who.int/icd/entity/1191191920 – Disorders of lipoprotein metabolism or certain specified lipidaemias
  • 3A10.Z – Hereditary haemolytic anaemia due to enzyme deficiency
  • 5A71.01 – Congenital adrenal hyperplasia
Show allHide
  • 5A81.1 – 5-alpha-reductase deficiency
  • LD28.01 – Marfan syndrome
  • LD28.1 – Ehlers-Danlos syndrome
  • LD2A.4 – androgen resistance syndrome
  • 18 – Pregnancy, childbirth or the puerperium
  • http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Sibling codes

  • 5C57.0 – Disorders of peroxisome biogenesis
  • 5C57.Y – Other specified peroxisomal diseases
  • 5C57.Z – Peroxisomal diseases, unspecified

Foundation entity

Disorders of peroxisomal alpha-, beta- or omega-oxidation – http://id.who.int/icd/entity/1092479335

Part of: 5C57: Peroxisomal diseases › 05: Endocrine, nutritional or metabolic diseases